2023/0491 - OCRELIZUMAB [300 MG/ 10 ML SOL INJ FRS]
TED · 376080-2026can-standardawardedNo deadline given
Buyer
NameUnidade Local de Saúde Santa Maria, E.P.E.
CountryPT
Published2026-06-02
Deadline—
Value
Estimated€489,240 · 489,239.7 EUR
Awarded—
WinnerROCHE Farmacêutica Química, LDA
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
OCRELIZUMAB [300 MG/ 10 ML SOL INJ FRS]
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-06-02 | 2023/0491 - OCRELIZUMAB [300 MG/ 10 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 100% |
| 2026-06-24 | 2023/0491 - ECULIZUMAB [300 MG SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 98% |
| 2026-06-24 | 2023/0491 - ECULIZUMAB [300 MG SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 98% |
| 2026-05-12 | 2023/0491 - PEMBROLIZUMAB [25 MG/ ML 4 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-06-24 | 2023/0491 - VEDOLIZUMAB [300 MG PÓ CONC SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-06-24 | 2023/0491 - VEDOLIZUMAB [300 MG PÓ CONC SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
Records136,978 tendersNewest notice2026-06-24Last ingest2026-06-25 · TED daily 06:00Parser health (7d)all runs clean